Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Accounts Payable & Accrued Expense : ¥738 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co Accounts Payable & Accrued Expense?

Zhejiang Jolly Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥794 Mil) to Dec. 2024 (¥659 Mil) but then increased from Dec. 2024 (¥659 Mil) to Mar. 2025 (¥738 Mil).

Zhejiang Jolly Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2022 (¥597 Mil) to Dec. 2023 (¥576 Mil) but then increased from Dec. 2023 (¥576 Mil) to Dec. 2024 (¥659 Mil).

Zhejiang Jolly Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zhejiang Jolly Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jolly Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zhejiang Jolly Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

277.11

396.86

597.17

576.40

658.74

Zhejiang Jolly Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															699.51	876.34	794.08	658.74	737.96

Zhejiang Jolly Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zhejiang Jolly Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200

Website

http://www.zuoli.com

Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.

Executives

Shen Ai Ying	Executives
Chen Guo Fen	Executives
Yu You Qiang	Director
Chen Jian	Executives
Zheng Xue Gen	Director
Guo Yin Li	Supervisors
Wang Tao	Executives
Yang Jun De	Director
Chen Rui Xiang	Supervisors
Dong Hong Yu	Directors, executives
Zheng Chao Yi	Directors, executives
Zhu Xiao Ping	Executives
Wu Ying	Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co Headlines

No Headlines